Corrigendum to “Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial” [Eur. Urol. 86 (2024) 552–562]

IF 25.2 1区 医学 Q1 UROLOGY & NEPHROLOGY European urology Pub Date : 2025-06-01 Epub Date: 2025-04-08 DOI:10.1016/j.eururo.2025.03.008
Andrew J. Armstrong , Oliver Sartor , Johann de Bono , Kim Chi , Karim Fizazi , Bernd J. Krause , Ken Herrmann , Kambiz Rahbar , Scott T. Tagawa , Fred Saad , Tomasz M. Beer , Jiwen Wu , Osvaldo Mirante , Michael J. Morris
{"title":"Corrigendum to “Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial” [Eur. Urol. 86 (2024) 552–562]","authors":"Andrew J. Armstrong , Oliver Sartor , Johann de Bono , Kim Chi , Karim Fizazi , Bernd J. Krause , Ken Herrmann , Kambiz Rahbar , Scott T. Tagawa , Fred Saad , Tomasz M. Beer , Jiwen Wu , Osvaldo Mirante , Michael J. Morris","doi":"10.1016/j.eururo.2025.03.008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 6","pages":"Pages 738-739"},"PeriodicalIF":25.2000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European urology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0302283825001794","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
前列腺特异性抗原水平下降与接受[177Lu]Lu-PSMA-617治疗的转移性钙化耐药前列腺癌患者临床结果的关系》[Eur.
作者对补充资料补充表5中关于最佳放射学反应的报告中的一个小数据错误感到遗憾。在177Lu-PSMA-617组中,总体PSA较基线下降最佳的“增加”亚组中,具有可评估反应的进行性疾病(PD)患者的百分比应该是31%,而不是40%。PD患者数(n = 22)和分母(n = 71)保持正确。因此,表内的数据应读作‘ 22(31)’而不是‘ 22(40)’。作者还指出,该表中的行在垂直方向上略有偏差,但顺序正确。下载:下载高分辨率图片(521KB)下载:下载全尺寸图片
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European urology
European urology 医学-泌尿学与肾脏学
CiteScore
43.00
自引率
2.60%
发文量
1753
审稿时长
23 days
期刊介绍: European Urology is a peer-reviewed journal that publishes original articles and reviews on a broad spectrum of urological issues. Covering topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, the journal also highlights recent advances in techniques, instrumentation, surgery, and pediatric urology. This comprehensive approach provides readers with an in-depth guide to international developments in urology.
期刊最新文献
Re: Hiroshi Kitamura, Taiji Tsukamoto, Yoshiyuki Kakehi, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.008 Platinum Hall of Fame Congress Calendar Editorial Board Contents
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1